P. R. Sundaresan - Concepedia

Author

P. R. Sundaresan

Also Known As

P R Sundaresan, P Ramnathan Sundaresan, P Sundaresan, P. R. SUNDARESAN, P. R. Sundaresan, P. Ramnathan Sundaresan, P. Sundaresan, P.R. Sundaresan, P.Ramnathan Sundaresan, PAVUR R. SUNDARESAN

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

University of Rochester Bayer (United States)Center for Food Safety and Applied Nutrition St. Joseph Hospital University of Rochester Medical Center

About

P. R. Sundaresan is an author at University of Rochester specializing in medicine, physiology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	19	926
2	Health Sciences	6	6	288
3	Public Health	2	2	43
4	Engineering	1	1	21
5	Social Sciences	1	1	28

P. R. Sundaresan

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Lack of effect of ketoconazole-mediated CYP3A inhibition on sorafenib clinical pharmacokinetics Chetan Lathia, John Lettieri, Frank Cihon, Cancer Chemotherapy and Pharmacology Sorafenib Clinical PharmacokineticsMedicineClinical PharmacologyKetoconazole-mediated Cyp3a InhibitionPharmacotherapy	2005	207
Long-term weight control study I (weeks 0 to 34) Michael Weintraub, P. R. Sundaresan, Manish Madan, Clinical Pharmacology & Therapeutics	1992	172
Sympathetic neural modulation of the immune system Kelley S. Madden, Suzanne Y. Felten, David L. Felten, Brain Behavior and Immunity	1989	165
The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery disease Udho Thadani, William Smith, Stephen Nash, Journal of the American College of Cardiology Selective Phosphodiesterase-5 InhibitorCardiovascular DiseaseErectile DysfunctionMedicinePhysiology	2002	147
Effect of High‐Fat Breakfast and Moderate‐Fat Evening Meal on the Pharmacokinetics of Vardenafil, an Oral Phosphodiesterase‐5 Inhibitor for the Treatment of Erectile Dysfunction Prabhu Rajagopalan, Arthur Mazzu, Chenghua Xia, The Journal of Clinical Pharmacology	2003	108
A Biologically Active Metabolite of Vitamin A and Vitamin A Acid K Yagishita, P. R. Sundaresan, George Wolf Nature BiochemistryPhysiologyMetabolomic ProfilingBiologically Active MetaboliteSecondary Metabolite	1964	95
Decreased<i>β</i>- Adrenergic Receptors in Rat Heart in Streptozotocin-Induced Diabetes: Role of Thyroid Hormones<sup>*</sup> P. R. Sundaresan, Virendra K. Sharma, Scott I. Gingold, Endocrinology	1984	94
Long-term Weight Control Study VI Michael Weintraub, P. R. Sundaresan, Christopher Cox Clinical Pharmacology & Therapeutics	1992	86
Long-term weight control study II (weeks 34 to 104) Michael Weintraub, P. R. Sundaresan, Barbara Schuster, Clinical Pharmacology & Therapeutics ObesityMetabolic SyndromeBariatric SurgeryLifestyle ModificationPsychiatry	1992	74
A phase I open-label study evaluating the cardiovascular safety of sorafenib in patients with advanced cancer Anthony W. Tolcher, Leonard J. Appleman, Geoffrey I. Shapiro, Cancer Chemotherapy and Pharmacology	2010	68

Page 1